EHP Funds Inc’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-566,268
Closed -$68K 406
2022
Q3
$68K Buy
566,268
+19,600
+4% +$2.53K 0.01% 256
2022
Q2
$60K Buy
+546,668
New +$95K 0.01% 309

EHP Funds Inc's ZVSAW Position: Q4 2022 in Review

EHP Funds Inc sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 566,268 shares — an estimated $68K sold.

EHP Funds Inc first reported a position in ZVSAW in Q2 2022 and held it in 2 quarters. The position peaked at $68K in Q3 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • EHP Funds Inc reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • EHP Funds Inc sold 566,268 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $68K.
  • EHP Funds Inc first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q2 2022 and held it in 2 quarters.
  • EHP Funds Inc's ZyVersa Therapeutics, Inc. Warrants position peaked at $68K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on EHP Funds Inc's 13F filing for Q4 2022, filed 14 Feb 2023.